NCT02346604

Brief Summary

People with mild chronic obstructive pulmonary disease (COPD) can have significant physiological abnormalities and breathing inefficiency which become more pronounced during the stress of exercise, leading to intolerable breathing discomfort (dyspnea). To better understand the mechanisms of respiratory symptoms and exercise limitation in mild COPD, we will examine detailed lung function tests and other important measurements during rest and exercise in people with mild COPD compared with healthy non-smokers. This will be the first study to uncover the fundamental causes of breathing inefficiency and the related shortness of breath during physical exertion in patients with mild COPD. We hope to demonstrate that one simple measurement during exercise \[the relation (ratio) between the total amount of air breathed (ventilation) and the amount of carbon dioxide breathed out\] gives meaningful information about the extent of damage to the small airways and blood vessels in mild COPD and the overall gas exchanging function of the lungs, without the need for an arterial blood sample. This is a case-controlled observational study not involving an intervention. Participants will complete 2 visits approximately 1 week apart, each conducted at the same time of day. Visit 1 will consiste of screening for iligibility, symptom and activity assessments, pulmonary function tests and an incremental cycle cardiopulmonary exercise test (CPET) for familiarization purposes. Visit 2 will include spirometry followed by an incremental cycle CPET with detailed measures of ventilatory, gas exchange, sensory-perceptual and arterial blood gas responses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 27, 2015

Completed
Last Updated

November 20, 2015

Status Verified

November 1, 2015

Enrollment Period

1.5 years

First QC Date

January 7, 2015

Last Update Submit

November 19, 2015

Conditions

Keywords

exercise

Outcome Measures

Primary Outcomes (1)

  • ventilatory equivalent for carbon dioxide (VE/VCO2)

    Exercise will consist of a symptom-limited incremental test on a cycle ergometer

    Measured at its nadir during an exercise test. Participants will be followed for the amount of time taken to complete 2 study visits, an expected average duration between 1 and 2 weeks.

Secondary Outcomes (3)

  • dead space to tidal volume ratio (VD/VT)

    Measured at standardized work rates during exercise

  • arterial blood gas measurements

    Measured at standardized work rates during exercise

  • dyspnea intensity measured using the modified 10-point Borg scale

    Measured at standardized work rates during exercise

Study Arms (2)

Mild COPD

Symptomatic smokers with mild COPD

Healthy Control

Non-smokers, matched to mild COPD group for age (at least 50 years) and gender

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients fitting GOLD grade 1B criteria for mild COPD

You may qualify if:

  • Stable symptomatic patients with GOLD grade 1B mild COPD;
  • at least 50 years of age;
  • a cigarette smoking history ≥20 pack-years;
  • a Baseline Dyspnea Index focal score ≤9;
  • post-bronchodilator forced expiratory volume in 1 second (FEV1) ≥80 %predicted and an FEV1/forced vital capacity (FVC) ratio \<0.7 and \< lower limit of normal.

You may not qualify if:

  • clinically significant comorbidities;
  • contraindications to exercise testing;
  • history/clinical evidence of asthma;
  • body mass index \<18.5 or \>30 kg/m2;
  • use of supplemental oxygen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Respiratory Investigation Unit at Kingston General Hospital

Kingston, Ontario, K7L 2V7, Canada

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Denis E O'Donnell, MD, FRCPC

    Queen's University and Kingston General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 7, 2015

First Posted

January 27, 2015

Study Start

July 1, 2013

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

November 20, 2015

Record last verified: 2015-11

Locations